Neural Therapeutics Inc. CEO Ian Campbell responds to questions raised by Scientific Advisor Professor David Nutt in his presentation on the potentially revolutionary untapped effects of psychedelic medicine.
The presentation focused on what Professor Nutt describes as the utility of psychedelic compounds and their potential to transform the treatment of mental illness.
Today's question asks: "The opioid crisis has touched every sector of society and shows no sign of stopping. How do we prevent more people from becoming addicted?"
Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today.